<prompt> All of the following are tumor necrosis factorAdalimumabEtanerceptInfliximabAbciximab  <response>: Abciximab is a Fab fragment of the chimeric human-murine monoclonal antibody 7E3. Abciximab binds to the glycoprotein GP IIbIIIa receptor of human platelets and inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor, and other adhesive molecules Ref Davidson 23rd edition pg 946 